Cite
HARVARD Citation
Pang, X. et al. (2020). Combination of pegylated interferon‐alpha and nucleos(t)ide analogue treatment enhances the activity of natural killer cells in nucleos(t)ide analogue experienced chronic hepatitis B patients. Clinical and experimental immunology. pp. 80-92. [Online].